USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement
24-Dec-2015
North America
Market Research
9AB9-00-46-00-00
LS00160-NA-MR_17130
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.
Summary
Market Outlook
Current Regulatory Status of NGS Instruments
Evolution of NGS Testing
NGS for Clinical versus Research Applications
Market Outlook on NGS Clinical Markets—Global
NGS Clinical Landscape—China
NGS Clinical Landscape—United States
Untapped Market for Clinical Applications of NGS—Global
Opportunity Assessment for Clinical NGS
Use of NGS Technology—Global
NGS-based Companion Diagnostics a Near-term Possibility
Points to Consider
Current Protocols for Reimbursement
Success Stories of 3 Companies—What Drives Reimbursement?
Genomic Health
Veracyte
Veracyte (Illumina)
Summary of Reimbursement Coverage Best Practices
Top Bottlenecks
Lessons from Early Adopters
Survey on Clinical NGS
Survey on Clinical NGS (continued)
Key Conclusions and Future Outlook
Analysis from the Genetic Test Repository (GTR)
Test Purpose
Test Method—NGS, Microarray, Sanger, and CGH Based
Tests Offered By Location
Tests Offered By Location (continued)
Selected NGS-based Tests with Clinical Significance
Selected NGS-based Tests with Clinical Significance (continued)
Selected NGS-based Tests with Clinical Significance (continued)
NGS Clinical Test Provider Profiles
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
NGS Clinical Test Provider Profiles (continued)
List for DTC Genetic Testing
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
List for DTC Genetic Testing (continued)
FDA’s Warning Letters to Manufacturers
List of Approved Companion Diagnostic Kits
List of Approved Companion Diagnostic Kits (continued)
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | 9AB9-00-46-00-00 |
| Is Prebook | No |
Global Clinical Next-generation Sequencing Market
$1,500.00
Special Price $1,125.00 save 25 %